A Novel Bispecific Anti-GPRC5D × CD3 Antibody: A New Tr

Investigators assessed the efficacy of BsAb5003 in treating multiple myeloma, with the results showing that the therapy may be an effective treatment approach.

Related Keywords

Japan , Nagoya , Aichi , United States , Attaya Suvannasankha , Indiana University School Of Medicine , Nagoya City University , Janssen Biotech Inc , Division Of Hematology , Bren Simon Comprehensive Cancer Center , Bristol Myers Squibb , Indiana University Melvin , Indiana University School , Janssen Biotech , Drug Des Devel ,